Details
Stereochemistry | ACHIRAL |
Molecular Formula | C27H22Cl2N4 |
Molecular Weight | 473.396 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)\N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=CC=CC=C4N=C2C=C1NC5=CC=C(Cl)C=C5
InChI
InChIKey=WDQPAMHFFCXSNU-BGABXYSRSA-N
InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24+
Molecular Formula | C27H22Cl2N4 |
Molecular Weight | 473.396 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:10:06 UTC 2023
by
admin
on
Sat Dec 16 11:10:06 UTC 2023
|
Record UNII |
D959AE5USF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
770820
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
WHO-ATC |
J04BA01
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
2684
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
NCI_THESAURUS |
C258
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
WHO-VATC |
QJ04BA01
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
LIVERTOX |
NBK548658
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
646318
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
NDF-RT |
N0000175483
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
338811
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
436314
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.3
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2592
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | RxNorm | ||
|
D959AE5USF
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
2248
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
2030-63-9
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
100000092385
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
141046
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
DB00845
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
1138904
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
SUB06694MIG
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
DTXSID7022839
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
CLOFAZIMINE
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | Description: A reddish brown, fine powder; odourless or almost odourless.Solubility: Practically insoluble in water; slightly soluble in ethanol (~750 g/l) TS and in ether R.Category: Antileprosy drug.Storage: Clofazimine should be kept in a well-closed container.Additional information: Clofazimine melts at about 217 ?C. | ||
|
C47456
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
D002991
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
CLOFAZIMINE
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
Clofazimine
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
217-980-2
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
m3637
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | Merck Index | ||
|
692
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
3749
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY | |||
|
CHEMBL1292
Created by
admin on Sat Dec 16 11:10:07 UTC 2023 , Edited by admin on Sat Dec 16 11:10:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET ORGANISM->INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |